Compare TPB & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPB | TNDM |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2016 | 2013 |
| Metric | TPB | TNDM |
|---|---|---|
| Price | $104.62 | $21.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 16 |
| Target Price | ★ $93.75 | $22.44 |
| AVG Volume (30 Days) | 252.0K | ★ 2.2M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | $435,716,000.00 | ★ $1,007,001,000.00 |
| Revenue This Year | $29.47 | $8.59 |
| Revenue Next Year | $10.28 | $10.19 |
| P/E Ratio | $529.09 | ★ N/A |
| Revenue Growth | ★ 51.72 | 17.87 |
| 52 Week Low | $51.48 | $9.98 |
| 52 Week High | $110.55 | $38.28 |
| Indicator | TPB | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 63.60 |
| Support Level | $96.15 | $20.27 |
| Resistance Level | $106.75 | $22.10 |
| Average True Range (ATR) | 2.83 | 1.12 |
| MACD | 0.39 | -0.12 |
| Stochastic Oscillator | 84.23 | 72.66 |
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.